| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |